Fineline Cube

Follow:
14486 Articles
Takeda Q3 Revenue Drops 3.3% on VYVANSE Generics, Raises Full-Year Forecast
Company

Takeda Q3 Revenue Drops 3.3% on VYVANSE Generics, Raises Full-Year Forecast

Tyligand Bio Files Hong Kong IPO with Phase II KRAS G12D Inhibitor TSN1611
CompanyDeals

Tyligand Bio Files Hong Kong IPO with Phase II KRAS G12D Inhibitor TSN1611

Hengrui Cancer Combo Gets NMPA Nod for Liver Cancer Trials
CompanyDrug

Hengrui Cancer Combo Gets NMPA Nod for Liver Cancer Trials

Genhouse Bio Files Hong Kong IPO with Phase II SHP2 Inhibitor GH21
CompanyDeals

Genhouse Bio Files Hong Kong IPO with Phase II SHP2 Inhibitor GH21

CSPC Pharma Signs $18.5B AstraZeneca Deal for Weight Management Portfolio
CompanyDeals

CSPC Pharma Signs $18.5B AstraZeneca Deal for Weight Management Portfolio

Sanofi Reports 9.9% Sales Growth to EUR 43.6B, Driven by Dupixent and China
Company

Sanofi Reports 9.9% Sales Growth to EUR 43.6B, Driven by Dupixent and China

Roche Reports 7% Sales Growth to CHF 61.5B, Driven by Pharma and China
Company

Roche Reports 7% Sales Growth to CHF 61.5B, Driven by Pharma and China

United Labs TUL108 Gets FDA Nod for Antibiotic Resistance Trial
CompanyDrug

United Labs TUL108 Gets FDA Nod for Antibiotic Resistance Trial

Fosun Pharma Licenses HPV DNA Drug VGX-3100 from ApolloBio for Greater China
CompanyDeals

Fosun Pharma Licenses HPV DNA Drug VGX-3100 from ApolloBio for Greater China

Kanghua to Acquire NanoRibo in Phased Deal for mRNA Platform
CompanyDeals

Kanghua to Acquire NanoRibo in Phased Deal for mRNA Platform

Lisata Reclaims Certepetide China Rights Amid Kuva Acquisition, CVR Milestone Triggered
CompanyDeals

Lisata Reclaims Certepetide China Rights Amid Kuva Acquisition, CVR Milestone Triggered

WuXi Biologics Partners with Sinorda on SND006 Bispecific Antibody for Autoimmune Diseases
CompanyDeals

WuXi Biologics Partners with Sinorda on SND006 Bispecific Antibody for Autoimmune Diseases